-13.36%07-07“The $880 written at entry came due today — in a three-day, 17% waterfall the stop was the only thing that never renegotiated. The supercycle story isn't dead, but a +243% YTD holder base needs one full changing of hands; wait for the sentiment low around CXMT's 7/27 listing before discussing a second boarding”
Score6/10Stop executed Closed at $853, through the $880 stop — position closedThree-day slide ~-17%; market cap back below $1TFresh negatives CXMT's $8.55B IPO prices (lists 7/27) + the TSMC capex shockWSB mentions 841 — #1 for a third straight dayYTD gain (pre-pullback) +243%
Technicals — Closed at $853.20 through both the $880 stop and the 50-day ($930) on just 1.06x volume — day three came without a volume spike, which reads as orderly distribution, not a panic low. The 7-day RSI at 30.8 nears oversold; next support is the $800 round number and May shelf, with the 20-day far above at $1,033.
Fundamentals — The fundamentals didn't change — the other side of the trade did. HBM 2026 capacity is sold out with orders booked into 2027, but CXMT (the world's #4 DRAM maker at 7.7% share) just priced China's largest-ever semiconductor IPO at RMB 57.9B for a 7/27 listing — the China-capacity story graduated from rumor to prospectus. A single unverified report adds possible tighter US HBM export rules.
News — TSMC's capex raise to $60–64B triggered a sector-wide valuation scare with the SOX down ~4%. Morningstar warns AI names could give back 20–30% while BofA counter-raised SanDisk to a $2,500 target — the bull-bear split has never been this wide, and Buffett's 'everybody is gambling' line still tops the tape.
Short-term · 1–3 weeks
NeutralSidelines
This long settles around -8% to -9% since the 7/2 baseline; the stop's value showed itself today — without $880 the conversation would be about -17%. Until CXMT lists and the HBM-export rumor resolves, memory is priced by sentiment, not earnings.
Entry Flat after the stop; a low-volume hammer at $800 with a 7-day-RSI divergence is the first reassessment point — no chasing below a reclaimed 50-day ($930)Stop —Target —
Long-term · months+
Neutral
HBM pricing power and pre-sold 2027 visibility remain best-in-class, and post-washout it stays a core watch — but CXMT's IPO-funded expansion forces a rethink of long-run non-HBM pricing assumptions.
CXMT's funded expansion eroding DRAM pricing
Direct hit if HBM export curbs materialize
Sustained volatility while the profit overhang clears
Signal BacktestCumulative -13.36%price itself -17.35%0/1 closed trades wonprofitable since 07-10
07-07Long$984.75 → closed $853.207-17-13.36%
Community Voices
WSB · 841 mentions for a third straight crown — from 'gift dip' to 'get out' to today's 'who's still in there', retail ran a full sentiment cycle in three daysOriginal ↗
StockTwits · Trending at 9.3 with bulls and bears warring over 'volatility pullback' vs 'cycle top' — nobody mentions the $1,255 from two weeks ago anymoreOriginal ↗
Institutional Views
华尔街共识 · 53 analysts average $1,579 — 85% above spot; the targets haven't caught up with the knife, don't use them as a handrail
24/7 Wall St · CXMT's $8.55B IPO is the new variable in this memory selloffSource ↗
Motley Fool · The post-TSMC sector dump did it; the fundamental case is unchangedSource ↗
-9.26%07-07“Last week its one-length lag behind NVIDIA was conspicuous; this week the length became a chasm — in the same arms race, the market grants pricing power to only one dealer. Exiting on the $518 break doesn't reject the company; it concedes that in an AI-chain unwind, the runner-up's beta hurts more than the leader's”
Score6/10Stop executed Closed at $500.94, through the $518 stop — position closedGap vs NVDA -6.8% rolling 5-day vs NVIDIA's +1.4% (same data source)Location Closed right on the 50-day ($496)Consensus target $539 (+7.6%)RSI(14) 46.9
Technicals — Closed at $500.94 through the $518 stop, parking exactly on the 50-day at $496 — the last near support; failure there opens the $460 gap-fill. Volume was flat at 1.04x, and the weekly scissors versus NVIDIA (+0.33%) widened to eight points.
Fundamentals — No company-specific negative — which is precisely the problem: under the TSMC capex shock the market re-ranked the AI chain by pricing power, and AMD's share-for-margin MI playbook with hyperscalers gets treated as pure beta in a risk-off. With consensus at $539, just 7.6% above, the crowding was already spent.
News — Down 5.3% in the TSMC-capex panic alongside memory's third leg (Intel -4.4%, Marvell -8.7%, extending losses on capex fears a day after Erste's valuation downgrade). Its next self-defense comes at early-August earnings — until then, the signal ledger owes it no direction.
Short-term · 1–3 weeks
NeutralSidelines
This long settles near -9% since the 7/7 entry. Relative strength drove the exit: within a sector you hold only the strongest, and right now that isn't AMD.
Entry Flat and watching: a low-volume hold at the 50-day ($496) plus a narrowing NVIDIA scissors is the reassessment trigger; a break targets the $460 gapStop —Target —
Long-term · months+
Neutral
The MI roadmap and server-CPU share story are intact and the valuation reasonable; reassess after the AI unwind passes and August earnings confirm data-center guidance.
MI margins capped by hyperscaler bargaining
NVIDIA's deepening lock-in squeezing the niche
If AI capex truly slows, second-source suppliers bleed first
Signal BacktestCumulative -9.26%price itself -7.38%0/1 closed trades wonprofitable since 07-11
07-07Long$552.05 → closed $500.9407-17-9.26%
Community Voices
StockTwits · Trending at 7.5 with 'why does it fall when NVDA doesn't' as the top question — asking it is already half the answerOriginal ↗
Institutional Views
华尔街共识 · 59 analysts average $539 — 7.6% above spot at a 1.28 rating; one of the thinnest consensus cushions on the board
-6.84%07-07“0.27% above the stop with a $17 ATR — this is no longer a position, it's a coin toss waiting for the market to press your button. The IBM tuition already taught the lesson: full size into earnings means outsourcing discipline to a gap. If it's still on this line at Monday's close, we pull the trigger ourselves and leave nothing to 7/22's luck”
Score6/10To the stop $390 — just 0.27%Earnings 7/22 (next Wednesday) — three sessions awayATR $17.12 — the stop sits just ~0.06 ATR awayRel. volume 0.73 — a low-volume standoffThe plan Still pinned at Monday's close → close before the print
Technicals — Down 0.9% to $391.06, a fourth day nailed just above the $390 stop. All three averages press from overhead (20-day $398.63, 50-day $409.97, 200-day $417.36) on 0.73x volume — neither side will act, ceding the decision to earnings week's first volume candle.
Fundamentals — The 7/22 suspense is still margin (was the 480k delivery quarter bought with cuts?) against a $0.27 EPS consensus. No new fundamental input this week — which is exactly the danger: price on the stop, an information vacuum and an imminent event combine every downside of waiting passively.
News — No company news; its -0.9% held up relatively well through the AI unwind, but resilience earns no prize 0.27% above a stop line.
Short-term · Into 7/22 earnings
LongBullish
This is the position's final holding statement: it must reclaim the 20-day ($399) on its own, or Monday's close ends the trade. After IBM, 'wait for the earnings flip' is no longer a legal strategy in this ledger.
Entry Hold with a double trigger: an intraday $390 break means exit, and a Monday (7/20) close below $395 means closing before earnings — either one fires, we executeStop $390Target $430
Long-term · months+
Neutral
The robotaxi/FSD and storage options are real but priced; no new long-term chips before the 7/22 margin answer.
Margin miss
Positioning squeezes into the print
Brand noise from political exposure
Signal BacktestCumulative -6.84%price itself -8.05%
07-07Long$419.77 → open → $391.06-6.84%
Institutional Views
华尔街共识 · 51 analysts average $407.48 — 4.2% above spot at a 1.77 rating; consensus offers no cushion into the print
+6.59%07-07“Through two days of AI-chain bloodletting it rose 5.8% to a record — the market's cash vote on who doesn't have to fund the $64 billion capex bill. With the 7-day RSI at 81.6, the right move is neither applause nor an exit: lift the stop another notch and let other people's panic keep carrying your chair”
Score7/10Record high $334.68 intraday; closed $333.26Two days +5.8% while the Nasdaq lost 0.9%RSI(14) / RSI(7) 71.4 / 81.6Consensus target $318.76 — now 4.4% below spotStop Raised $308→$315
Technicals — Up 1.8% to a record $334.68 intraday on 1.3x volume. RSI(14) at 71.4 runs hot — exactly how trend leaders behave. Nothing overhead; the $315 shelf and $308 MA cluster form double support below, ATR $8.30.
Fundamentals — The haven-plus-certainty repricing keeps unfolding: cash flow, buybacks and ecosystem lock-in get panic-bought on every AI scare, with StockTwits calling it a 'major safe-haven asset' outright. Consensus targets trail the price by 4.4% — the upgrade cycle is the most certain tailwind from here.
News — No company news; the entire +5.8% two-day run came from migration — money exiting fallen IBM, cratering memory and unwinding neoclouds needs a container big enough to hold it.
Short-term · 1–3 weeks
LongBullish
Migration-driven advances don't end until the panic does; the raised stop banks most of this leg's gain — let it run on the upside, with $315 underwriting the down.
Entry Hold with the stop raised $308→$315 (2.2 ATRs); no adds at an 81.6 seven-day RSI — the $320–325 retest is the boarding zoneStop $315Target $350
Long-term · months+
Accumulate
Ecosystem cash flows, services growth and the on-device AI option; in a turbulent market the certainty premium compounds rather than inflates.
A technical pullback off overbought readings
Two-way volatility when haven money rotates out
China demand and tariff noise
Signal BacktestCumulative +6.59%price itself +1.76%profitable since 07-09
07-07Long$312.66 → open → $333.26+6.59%
Community Voices
StockTwits · Trending at 15.5 as 'safe haven' becomes its new label — when a growth stock earns that name, holders should smile and chasers should sober upOriginal ↗
WSB · Mentions 68→101 with record-day posts split between celebration and 'waiting for the dip' — the dip-waiters have now waited through $30 of upsideOriginal ↗
Institutional Views
华尔街共识 · 52 analysts average $318.76, 4.4% below spot — day three of price leading consensus; the upgrade wave is en route
-7.37%07-14“From kicking down the 130 door to breaking the 122 stop took exactly three sessions — a complete autopsy of a failed breakout. The 20% weekly fuel was itself the profit overhang, and the exchange filing's 'nothing undisclosed' translates to 'no reason up, no reason down.' The -7.4% buys one lesson: chasing breakouts is fine, but the first failed retest means leaving — and this exit wasn't slow”
Score6/10Stop executed HK$118.20 this morning, through the HK$122 stop — closedThe trade Opened 7/14 at 127.60 → closed at 118.20, ~-7.4%Nature of the drop No fresh negative — the A-shares confirmed 'nothing undisclosed' on 7/15Context Institutional profit-taking after a 20% week, plus fund-settlement trimmingRSI(14) 54.9
Technicals — Down 8.2% this morning at HK$118.20, through both the HK$122 stop and the 130 breakout shelf, back to the last cushion above the 20-day (HK$113.91). RSI collapsed from 70 to 54.9 — a breakout structure dissolving inside three days, the classic failed-breakout timestamp.
Fundamentals — The fundamental script didn't change — the CXO order recovery, the H-share incentive and HK$136 bank targets all stand. The positioning changed: a 20% three-day A-share deviation triggered an exchange review, Soochow's weekly showed it topping the sector at +19.85%, and half-year fund settlement found its fattest target.
News — The 7/15 A-share filing confirmed nothing undisclosed; HK pharma began pulling back 7/16 (this name -3.7%, Joinn -6%); this morning the slide accelerated. The three-day timeline points squarely at profit-taking, not a fundamental event — BIOSECURE became law in December 2025 and added nothing new this round.
Short-term · 1–3 weeks
NeutralSidelines
This trade settles at -7.4%. Profit-taking declines leave fundamentals intact but never announce how many floors they'll shed — let the 20-day do the counting for us.
Entry Flat and watching: a low-volume hold at the 20-day (HK$113.91) with WuXi Bio stabilizing in tandem keeps the CXO theme alive — HK$110–114 is the re-entry evaluation zone; below the 20-day, this entire leg is overStop —Target —
Long-term · months+
Accumulate
The medium-term case — CXO recovery, peptide torque, aligned incentives — is intact; once positioning digests, it remains a core HK pharma theme name.
The profit-taking cutting deeper than expected
Geopolitical (BIOSECURE-style) risk resurfacing
Interims missing the bar the rally implied
Signal BacktestCumulative -7.37%price itself -7.37%0/1 closed trades wonprofitable since 07-16
07-14LongHK$127.6 → closed HK$118.207-17-7.37%
Community Voices
雪球 · The profit-screenshot posts from three days ago now teach 'how to spot failed breakouts' — the market's most efficient school has always been the lossOriginal ↗
Institutional Views
华尔街共识 · 8 analysts average HK$135.96 — 15% above spot; the targets didn't move, holders' patience did
新浪财经 · The A-share filing: no undisclosed material mattersSource ↗
+14.97%07-02“It closed dead level with the 50-day yesterday, and before answering today's exam the US chip crash walked in as proctor — retreating 0.8% below the line isn't a blank paper, and falling just 1.6% amid the chip bloodbath is extra credit. The HK$108 stop sits safely above cost; retakes are allowed here, but failing to hand in the paper below 110 is not”
Score7/10The 50-day exam Level yesterday; 0.8% below the line this morningThis morning -1.6% — relatively firm in the risk-offWeek +4.5%Stop HK$108Position P&L ~+15% since inclusion
Technicals — Down 1.6% this morning at HK$115.00, 0.8% back under the 50-day (HK$115.89). The RSI-7 at 73.7 bleeds off its heat into the dip; the HK$110 round number and gap form second support with the HK$108 stop beneath — structure intact, exam merely postponed.
Fundamentals — The ~45% cloud-growth preview and the Qwen 3.7 flagship suite (Qwen3.7-Max/Plus) keep the re-rating case unchanged. WAIC 2026 opens in Shanghai today (7/17–20) — a dense catalyst window that resupplies Alibaba's narrative, even as it turns 'news to sell' for the already-run AI model names like MiniMax.
News — No company news; with the Hang Seng opening lower on the US tape, its -1.6% ranks among the book's most resilient — week two of the AI re-rating, and the money hasn't left.
Short-term · 1–3 weeks
LongBullish
An external pullback (US chips) doesn't overrule the internal case (cloud + AI re-rating); a position stopped above cost can afford to wait for the exam to reopen, with four days of WAIC as potential narrative resupply.
Entry Hold with the HK$108 stop unchanged; a volume reclaim of HK$116 (the 50-day) restarts the advance, and a quiet HK$110–112 retest is the boarding zoneStop HK$108Target HK$130
Long-term · months+
Accumulate
Early-stage cloud+AI re-rating at a valuation discount, with commerce cash flow funding the capex cycle.
The US AI unwind transmitting deeper into HK
Momentum decay after three failed runs at the 50-day
LLM monetization underdelivering
Signal BacktestCumulative +14.97%price itself +22.21%0/1 closed trades wonprofitable since 07-09
07-02LongHK$94.5 → closed HK$94.107-04-0.42%
07-08LongHK$99.6 → open → HK$115+15.46%
Community Voices
雪球 · Feeds full of 'does losing the 50-day count as a breakdown' chart posts — volume holds the real answer: a quiet retreat is rest, a loud one is a vetoOriginal ↗
Down 2.4% to $207.40, 1.2% above the $205 stop — the arms dealer finally took one head-on; a break means exit, for the relative-strength story only exists above the line
Down 7.9% to $28.39 through the $30.50 stop — closed out. Three days of stalemate bought a catch-down, not a bounce; the trade settles near -9%, and the gene-editing M&A dream can reschedule
Down 4.4% this morning at HK$37.60 — the other half of the CXO duet is taking hits too, but it sits 6.9% above its HK$35 stop; Asymchem is out, this one isn't, and each discipline runs its own book
Down 6.9% this morning at HK$96.40, just 1.5% above the HK$95 stop — the high-beta bill of a gold-squeeze day; tomorrow it bounces or discipline takes over
